Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysis
- PMID: 29860151
- DOI: 10.1016/j.tmaid.2018.05.016
Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysis
Abstract
Background: Invasive pneumococcal disease (IPD) is associated with high morbidity and mortality, with immunocompromised patients (ICPs) at particular risk. Therefore, guidelines recommend pneumococcal vaccination for these patients. However, guidelines are scarcely underpinned with references to incidence studies of IPD in this population. This, potentially results in unawareness of the importance of vaccination and low vaccination rates. The objective of this systematic review and meta-analysis was to assess the incidence of IPD in ICPs.
Methods: We systematically searched PubMed and Embase to identify studies in English published before December 6th, 2017 that included terms related to 'incidence', 'rate', 'pneumococcal', 'pneumoniae', 'meningitis', 'septicemia', or 'bacteremia'. We focused on patients with HIV, transplantation and chronic inflammatory diseases.
Results: We included 45 studies in the systematic review reporting an incidence or rate of IPD, defined as isolation of Streptococcus pneumoniae from a normally sterile site. Random effects meta-analysis of 38 studies showed a pooled IPD incidence of 331/100,000 person years in patients with HIV in the late-antiretroviral treatment era in non-African countries, and 318/100,000 in African countries; 696 and 812/100,000 in patients who underwent an autologous or allogeneic stem cell transplantation, respectively; 465/100,000 in patients with a solid organ transplantation; and 65/100,000 in patients with chronic inflammatory diseases. In healthy control cohorts, the pooled incidence was 10/100,000.
Discussion: ICPs are at increased risk of contracting IPD, especially those with HIV, and those who underwent transplantation. Based on our findings, we recommend pneumococcal vaccination in immunocompromised patients.
Prospero registration: ID: CRD42016048438.
Keywords: Chronic inflammatory diseases; Human immunodeficiency; Immunocompromised; Incidence rate; Invasive pneumococcal disease; Transplantation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Childhood pneumococcal disease in Africa - A systematic review and meta-analysis of incidence, serotype distribution, and antimicrobial susceptibility.Vaccine. 2017 Apr 4;35(15):1817-1827. doi: 10.1016/j.vaccine.2017.02.045. Epub 2017 Mar 9. Vaccine. 2017. PMID: 28284682 Free PMC article.
-
Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.PLoS One. 2017 May 9;12(5):e0177113. doi: 10.1371/journal.pone.0177113. eCollection 2017. PLoS One. 2017. PMID: 28486544 Free PMC article.
-
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004977. doi: 10.1002/14651858.CD004977. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD004977. doi: 10.1002/14651858.CD004977.pub2. PMID: 15495133 Updated.
-
Influenza vaccines in immunosuppressed adults with cancer.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD008983. doi: 10.1002/14651858.CD008983.pub3. Cochrane Database Syst Rev. 2018. PMID: 29388675 Free PMC article.
-
Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.Vaccine. 2017 May 19;35(22):2882-2891. doi: 10.1016/j.vaccine.2017.04.032. Epub 2017 Apr 24. Vaccine. 2017. PMID: 28449971
Cited by
-
A Nationwide Digital Multidisciplinary Intervention Aimed at Promoting Pneumococcal Vaccination in Immunocompromised Patients.Vaccines (Basel). 2023 Aug 11;11(8):1355. doi: 10.3390/vaccines11081355. Vaccines (Basel). 2023. PMID: 37631923 Free PMC article.
-
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients.Arthritis Res Ther. 2020 Feb 22;22(1):36. doi: 10.1186/s13075-020-2124-3. Arthritis Res Ther. 2020. PMID: 32087733 Free PMC article.
-
Routine and Special Vaccinations in People With HIV.Top Antivir Med. 2024 Apr 18;32(2):411-419. Top Antivir Med. 2024. PMID: 39141919 Free PMC article. Review.
-
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy.Vaccines (Basel). 2022 May 17;10(5):795. doi: 10.3390/vaccines10050795. Vaccines (Basel). 2022. PMID: 35632551 Free PMC article.
-
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.JAMA Netw Open. 2023 Apr 3;6(4):e2310687. doi: 10.1001/jamanetworkopen.2023.10687. JAMA Netw Open. 2023. PMID: 37115546 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical